Tumor Agnostic Models for NSCLC Drug Development

2022 ◽  
Vol 112 (2) ◽  
pp. e19
Author(s):  
P. Hays
Keyword(s):  
Drug Development

A update of botanical drug development in the United States: Status of applications

Planta Medica ◽  
2015 ◽  
Vol 81 (11) ◽  
Author(s):  
KM Wu ◽  
C Wu ◽  
J Dou ◽  
H Ghantous ◽  
S Lee ◽  
...  
Keyword(s):  
United States ◽  
Drug Development ◽  
The United States ◽  
Botanical Drug

Comparative Pharmacology of Site Directed Antithrombin Agents. Implication in Drug Development

1995 ◽  
Vol 74 (01) ◽  
pp. 473-481 ◽  
Author(s):  
Demetra Callas ◽  
Jawad Fareed
Keyword(s):  
Drug Development

A Basic Study on Collaborative Plan of Translational Service Research for Accelerating New Drug Development

2014 ◽  
Vol 15 (1) ◽  
pp. 283-306
Author(s):  
Kim, Chang Won ◽  
Lee Cheol-Gyu ◽  
Youn Sung Kim ◽  
WangJin Yoo
Keyword(s):  
Drug Development ◽  
Service Research ◽  
Basic Study ◽  
New Drug ◽  
New Drug Development

943-P: Role of Model-Informed Drug Development in Confirming Additional Clinical Benefits of Dulaglutide

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 943-P
Author(s):  
LAI-SAN THAM ◽  
JEANNE GEISER ◽  
CHENG CAI TANG ◽  
KAREN SCHNECK ◽  
DAVID COX ◽  
...  
Keyword(s):  
Drug Development ◽  
Clinical Benefits
Sign in / Sign up

Export Citation Format

Share Document